Department of Health Sciences, ARRC Building, University of York, Heslington, York, YO10 5DD, UK.
School of Pharmacy, University College London, 29-39 Brunswick Square, London, WC1N 1AX, UK.
Res Social Adm Pharm. 2020 Feb;16(2):111-122. doi: 10.1016/j.sapharm.2019.04.010. Epub 2019 Apr 19.
Medicines Use Reviews (MURs) and the New Medicine Service (NMS) are services delivered by UK community pharmacists to improve adherence, improve patient understanding of their medicines and reduce medicines wastage.
In this scoping review we aim to identify, map and critically examine the nature of existing empirical evidence in peer reviewed journals relating to MUR and NMS consultations.
Systematic searches identified the available MUR and NMS empirical literature. We sought data on barriers and facilitators to conducting MUR or NMS consultations, the perceptions of pharmacists and patients, the conduct of consultations, and outcomes of consultations. Searches from 2005 (when MURs were introduced) to May 2018 were conducted in MEDLINE, PsycINFO, Embase and Scopus databases. Data were extracted into Excel for examination of study characteristics, participant characteristics, type of intervention/services delivered and key study quantitative and/or qualitative findings.
Forty-one papers from 37 studies met the inclusion criteria: 28 papers were of MURs, 10 of NMS and 3 for both services. Studies focused on the introduction and implementation of these services, with little attention to outcomes for patients; effectiveness was not evaluated beyond in a single NMS RCT. Observational data indicated that pharmacists and patients view MURs and the NMS positively, despite challenges implementing these services and apparent lack of communication between pharmacists and GPs. Consultations were reported to be short, typically 10-12 min, characterised by limited engagement with patients and their health problems. The extent and nature of advice on health behaviours during consultations or other content was rarely examined.
The research literature on MURs and the NMS has developed slowly. There is much scope for further research attention to developing more patient-centred care.
药品使用审查（MUR）和新药服务（NMS）是英国社区药剂师提供的服务，旨在提高患者的服药依从性、增强其对药物的理解并减少药物浪费。
本综述旨在确定、绘制并批判性地审视已发表的同行评议期刊中与 MUR 和 NMS 咨询相关的现有实证证据的性质。
系统检索确定了可用的 MUR 和 NMS 实证文献。我们寻求有关开展 MUR 或 NMS 咨询的障碍和促进因素、药剂师和患者的看法、咨询的开展以及咨询结果的数据。检索范围从 2005 年（MUR 推出）到 2018 年 5 月，检索 MEDLINE、PsycINFO、Embase 和 Scopus 数据库。将数据提取到 Excel 中，以检查研究特征、参与者特征、干预措施/提供的服务类型以及主要研究的定量和/或定性结果。
从 37 项研究中筛选出 41 篇符合纳入标准的论文：28 篇为 MUR 研究，10 篇为 NMS 研究，3 篇为两项服务的研究。研究重点是这些服务的引入和实施，而对患者的结果关注较少；除了一项 NMS 的 RCT 外，未评估这些服务的有效性。观察性数据表明，尽管在实施这些服务方面存在挑战，且药剂师和全科医生之间似乎缺乏沟通，但药剂师和患者对 MUR 和 NMS 的看法是积极的。咨询通常持续 10-12 分钟，特点是与患者及其健康问题的互动有限。在咨询期间或其他内容中关于健康行为的建议的程度和性质很少受到关注。
MUR 和 NMS 的研究文献发展缓慢。进一步研究关注发展更以患者为中心的护理具有很大的空间。
